Kaken Pharmaceutical Co., Ltd. (4521.T)

JPY 4026.0

(1.21%)

Inventory Summary of Kaken Pharmaceutical Co., Ltd.

  • Kaken Pharmaceutical Co., Ltd.'s latest annual inventory in 2023 was 17.16 Billion JPY , up 10.31% from previous year.
  • Kaken Pharmaceutical Co., Ltd.'s latest quarterly inventory in 2024 Q1 was 17.08 Billion JPY , up 8.16% from previous quarter.
  • Kaken Pharmaceutical Co., Ltd. reported annual inventory of 15.56 Billion JPY in 2022, up 3.89% from previous year.
  • Kaken Pharmaceutical Co., Ltd. reported annual inventory of 14.98 Billion JPY in 2021, down -1.43% from previous year.
  • Kaken Pharmaceutical Co., Ltd. reported quarterly inventory of 17.16 Billion JPY for 2023 FY, up 10.31% from previous quarter.
  • Kaken Pharmaceutical Co., Ltd. reported quarterly inventory of 17.85 Billion JPY for 2023 Q2, up 6.08% from previous quarter.

Annual Inventory Chart of Kaken Pharmaceutical Co., Ltd. (2023 - 2004)

Historical Annual Inventory of Kaken Pharmaceutical Co., Ltd. (2023 - 2004)

Year Inventory Inventory Growth
2023 17.16 Billion JPY 10.31%
2022 15.56 Billion JPY 3.89%
2021 14.98 Billion JPY -1.43%
2020 15.19 Billion JPY 23.81%
2019 12.27 Billion JPY -10.53%
2018 13.71 Billion JPY -17.61%
2017 16.65 Billion JPY 0.95%
2016 16.49 Billion JPY 13.71%
2015 14.5 Billion JPY 7.6%
2014 13.48 Billion JPY 1.98%
2013 13.22 Billion JPY 14.65%
2012 11.53 Billion JPY 5.56%
2011 10.92 Billion JPY 6.07%
2010 10.29 Billion JPY 14.54%
2009 8.99 Billion JPY -17.84%
2008 10.94 Billion JPY 10.13%
2007 9.93 Billion JPY 8.9%
2006 9.12 Billion JPY -5.5%
2005 9.65 Billion JPY -5.78%
2004 10.24 Billion JPY 0.0%

Peer Inventory Comparison of Kaken Pharmaceutical Co., Ltd.

Name Inventory Inventory Difference
Pharma Foods International Co., Ltd. 6.71 Billion JPY -155.575%
Takeda Pharmaceutical Company Limited 1209.86 Billion JPY 98.581%
Sumitomo Pharma Co., Ltd. 115.35 Billion JPY 85.117%
Shionogi & Co., Ltd. 64.91 Billion JPY 73.555%
Wakamoto Pharmaceutical Co.,Ltd. 2 Billion JPY -755.768%
Nippon Shinyaku Co., Ltd. 39.11 Billion JPY 56.107%
Eisai Co., Ltd. 174.65 Billion JPY 90.171%
Morishita Jintan Co., Ltd. 3.18 Billion JPY -438.995%
Hisamitsu Pharmaceutical Co., Inc. 21.17 Billion JPY 18.932%
Mochida Pharmaceutical Co., Ltd. 30.27 Billion JPY 43.302%
Fuso Pharmaceutical Industries,Ltd. 14.2 Billion JPY -20.877%
Nippon Chemiphar Co., Ltd. 10.72 Billion JPY -60.11%
Tsumura & Co. 117.61 Billion JPY 85.404%
Kissei Pharmaceutical Co., Ltd. 26.29 Billion JPY 34.716%
Torii Pharmaceutical Co., Ltd. 10.74 Billion JPY -59.812%
Towa Pharmaceutical Co., Ltd. 101.07 Billion JPY 83.015%
Fuji Pharma Co., Ltd. 19.37 Billion JPY 11.378%
Zeria Pharmaceutical Co., Ltd. 14.48 Billion JPY -18.477%
KYORIN Holdings, Inc. 53.47 Billion JPY 67.894%
Taiko Pharmaceutical Co.,Ltd. 1.95 Billion JPY -779.457%
Daito Pharmaceutical Co.,Ltd. 20.89 Billion JPY 17.822%
SymBio Pharmaceuticals Limited 232.03 Million JPY -7298.612%
MedRx Co., Ltd 10 Million JPY -171570.0%
Mizuho Medy Co.,Ltd. 1.59 Billion JPY -975.217%
Solasia Pharma K.K. 122 Million JPY -13971.311%
Modalis Therapeutics Corporation 6.35 Million JPY -270118.794%
ASKA Pharmaceutical Holdings Co.,Ltd. 20.4 Billion JPY 15.856%
Sawai Group Holdings Co., Ltd. 100 Billion JPY 82.833%
Cyfuse Biomedical K.K. 46.04 Million JPY -37183.093%
Toho Holdings Co., Ltd. 87.28 Billion JPY 80.333%
Koa Shoji Holdings Co.,Ltd. 2.26 Billion JPY -657.504%